Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Mar 31:14:232.
doi: 10.1186/1471-2407-14-232.

Can an alert in primary care electronic medical records increase participation in a population-based screening programme for colorectal cancer? COLO-ALERT, a randomised clinical trial

Affiliations
Randomized Controlled Trial

Can an alert in primary care electronic medical records increase participation in a population-based screening programme for colorectal cancer? COLO-ALERT, a randomised clinical trial

Carolina Guiriguet-Capdevila et al. BMC Cancer. .

Abstract

Background: Colorectal cancer is an important public health problem in Spain. Over the last decade, several regions have carried out screening programmes, but population participation rates remain below recommended European goals. Reminders on electronic medical records have been identified as a low-cost and high-reach strategy to increase participation. Further knowledge is needed about their effect in a population-based screening programme. The main aim of this study is to evaluate the effectiveness of an electronic reminder to promote the participation in a population-based colorectal cancer screening programme. Secondary aims are to learn population's reasons for refusing to take part in the screening programme and to find out the health professionals' opinion about the official programme implementation and on the new computerised tool.

Methods/design: This is a parallel randomised trial with a cross-sectional second stage.

Participants: all the invited subjects to participate in the public colorectal cancer screening programme that includes men and women aged between 50-69, allocated to the eleven primary care centres of the study and all their health professionals. The randomisation unit will be the primary care physician. The intervention will consist of activating an electronic reminder, in the patient's electronic medical record, in order to promote colorectal cancer screening, during a synchronous medical appointment, throughout the year that the intervention takes place. A comparison of the screening rates will then take place, using the faecal occult blood test of the patients from the control and the intervention groups. We will also take a questionnaire to know the opinions of the health professionals. The main outcome is the screening status at the end of the study. Data will be analysed with an intention-to-treat approach.

Discussion: We expect that the introduction of specific reminders in electronic medical records, as a tool to facilitate and encourage direct referral by physicians and nurse practitioners to perform colorectal cancer screening will mean an increase in participation of the target population. The introduction of this new software tool will have good acceptance and increase compliance with recommendations from health professionals.

Trial registration: Clinical Trials.gov identifier NCT01877018.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of the COLO-ALERT Study. PCP: Primary care physician, N: Nurse, CRCSP: Colorectal cancer screening programme, EMR: electronic medical record, BQ: baseline questionnaire, FQ: final questionnaire.
Figure 2
Figure 2
Study electronic alert. Specific icon (red dot) in front of the patient’s name on the list of appointments scheduled for the day.

References

    1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide. IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: [ http://globocan.iarc.fr], accessed on 11/05/2013]
    1. Ribes J, Navarro M, Cleries R, Esteban L, Pareja L, Binefa G, Peris M, Fernández E, Borràs JM. Colorectal cancer mortality in Spain: trends and projections for 1985–2019. Eur J Gastroenterol Hepatol. 2009;21:92–100. doi: 10.1097/MEG.0b013e32830b5f39. - DOI - PubMed
    1. Chirlaque MD, Salmerón D, Ardanaz E, Galceran J, Martínez R, Marcos-Gragera R, Sánchez MJ, Mateos A, Torrella A, Capocaccia R, Navarro C. Cancer survival in Spain: estimate for nine major cancers. Ann Oncol. 2010;21(Suppl 3):iii21–iii29. doi: 10.1093/annonc/mdq082. - PubMed
    1. Morillas JD, Castells A, Oriol I, Pastor A, Pérez-Segura P, Echevarría JM, Caballero B, González-Navarro A, Bandrés F, Brullet E, Iniesta A, Carballo F, Bouzas R, Ariza A, Ibisate A, García-Alfonso P, Escudero B, Camacho S, Fernández-Marcos A, González T, Quintero E, Lanas A, Marzo M, Mascort J, Andréu M, Cerezo L, Vázquez-Sequeiros E, Borrás JM, Salas D, Ascunce N. en representación de la Alianza para la Prevención del Cáncer de Colon en España et al.Alianza para la prevención del cáncer de colon en España: un compromiso cívico con la sociedad. Gastroenterol Hepatol. 2012;35(3):109–128. doi: 10.1016/j.gastrohep.2012.01.002. - DOI - PubMed
    1. Wilson JMG, Junger G. Principles and Practice of Screening for Disease. Geneve: World Health Organization; 1968.

Publication types

Associated data